Volume 3, Issue 5, Page 1 (May 2008)
1 of 38
PREVIEW
FULL TEXT
FULL-TEXT PDF (226 KB)
CITATION ALERT
CITED BY
RELATED ARTICLES
EXPORT CITATION
EMAIL TO A COLLEAGUE
RIGHTS/PERMISSIONS
DOWNLOAD IMAGES
NEED REPRINTS?
BOOKMARK ARTICLE
CHICAGO — Treatment of type 2 diabetes with pioglitazone resulted in significant prevention of coronary atherosclerosis progression, compared with glimepiride, in a prospective, randomized study of 543 patients.
PII: S1558-0164(08)70163-9
doi:10.1016/S1558-0164(08)70163-9
© 2008 Elsevier Inc. All rights reserved.
Copyright © 2012 Elsevier Inc. All rights reserved. | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.